{"database": "lobbying", "table": "lobbying_activities", "rows": [[3219906, "efc6b5a0-fb6e-4552-8ac3-1ec4b8ba6df5", "Q2", "VIZIENT, INC.", 40021, "VIZIENT INC", 2024, "second_quarter", "TAR", "Sec. 301 China Tariffs - Continued to advocate for clarity around the expiration of tariff exclusions for products necessary to respond to the COVID-19 pandemic. Supported extending exclusions for key healthcare products. Provided feedback to the U.S. Trade Representatives (USTR) Request for Comments on Proposed Modifications and Machinery Exclusion Process in Four-Year Review of Actions Taken in the Section 301 Investigation: Chinas Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation (Docket No. USTR-2024-0007)", "HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)", null, 290000, 0, 0, "2024-07-22T15:58:33-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3219906"], "units": {}, "query_ms": 0.30211498960852623, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}